These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2259248)

  • 1. Application of brain microdialysis to study the pharmacology of the 5-HT1A autoreceptor.
    Sharp T; Hjorth S
    J Neurosci Methods; 1990 Sep; 34(1-3):83-90. PubMed ID: 2259248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. cis-(+)-8-OH-1-CH3-DPAT, (+)ALK-3, a novel stereoselective pharmacological probe for characterizing 5-HT release-controlling 5-HT1A autoreceptors. An in vivo brain microdialysis study.
    Hjorth S; Sharp T; Liu Y
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Mar; 341(3):149-57. PubMed ID: 1692973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential regulation of somatodendritic serotonin 5-HT1A receptors by 2-week treatments with the selective agonists alnespirone (S-20499) and 8-hydroxy-2-(Di-n-propylamino)tetralin: microdialysis and autoradiographic studies in rat brain.
    Casanovas JM; Vilaró MT; Mengod G; Artigas F
    J Neurochem; 1999 Jan; 72(1):262-72. PubMed ID: 9886078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the 5-HT1A receptor agonist 8-OH-DPAT on the release of 5-HT in dorsal and median raphe-innervated rat brain regions as measured by in vivo microdialysis.
    Hjorth S; Sharp T
    Life Sci; 1991; 48(18):1779-86. PubMed ID: 1826937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further investigation of the in vivo pharmacological properties of the putative 5-HT1A antagonist, BMY 7378.
    Sharp T; Backus LI; Hjorth S; Bramwell SR; Grahame-Smith DG
    Eur J Pharmacol; 1990 Feb; 176(3):331-40. PubMed ID: 1970304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Release of 5-hydroxytryptamine (5-HT) from medullary and mesencephalic raphé neurones after grafting to the rat hippocampus: evidence for regulation by 5-HT1A autoreceptors.
    Sharp T; Foster GA
    Neurosci Lett; 1991 Nov; 132(2):179-82. PubMed ID: 1838408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-dose 8-OH-DPAT pretreatment does not induce tachyphylaxis to the 5-HT release-reducing effect of 5-HT1A autoreceptor agonists.
    Hjorth S
    Eur J Pharmacol; 1991 Jun; 199(2):237-42. PubMed ID: 1835441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential regulation of serotonin (5-HT) release in the striatum and hippocampus by 5-HT1A autoreceptors of the dorsal and median raphe nuclei.
    Kreiss DS; Lucki I
    J Pharmacol Exp Ther; 1994 Jun; 269(3):1268-79. PubMed ID: 8014870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucocorticoid receptor-mediated inhibition by corticosterone of 5-HT1A autoreceptor functioning in the rat dorsal raphe nucleus.
    Laaris N; Haj-Dahmane S; Hamon M; Lanfumey L
    Neuropharmacology; 1995 Sep; 34(9):1201-10. PubMed ID: 8532191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions of (+)- and (-)-8- and 7-hydroxy-2-(di-n-propylamino)tetralin at human (h)D3, hD2 and h serotonin1A receptors and their modulation of the activity of serotoninergic and dopaminergic neurones in rats.
    Lejeune F; Newman-Tancredi A; Audinot V; Millan MJ
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1241-9. PubMed ID: 9067310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central pre- and postsynaptic 5-HT1A receptors in rats treated chronically with a novel antidepressant, cericlamine.
    Jolas T; Haj-Dahmane S; Kidd EJ; Langlois X; Lanfumey L; Fattaccini CM; Vantalon V; Laporte AM; Adrien J; Gozlan H
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1432-43. PubMed ID: 8138956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo assessment of the midbrain raphe nuclear regulation of serotonin release in the hamster suprachiasmatic nucleus.
    Dudley TE; Dinardo LA; Glass JD
    J Neurophysiol; 1999 Apr; 81(4):1469-77. PubMed ID: 10200183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of the selective 5-HT1A agonists alnespirone (S-20499) and 8-OH-DPAT on extracellular 5-hydroxytryptamine in different regions of rat brain.
    Casanovas JM; Lésourd M; Artigas F
    Br J Pharmacol; 1997 Oct; 122(4):733-41. PubMed ID: 9375971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of pindolol on the function of pre- and postsynaptic 5-HT1A receptors: in vivo microdialysis and electrophysiological studies in the rat brain.
    Romero L; Bel N; Artigas F; de Montigny C; Blier P
    Neuropsychopharmacology; 1996 Oct; 15(4):349-60. PubMed ID: 8887989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic electroconvulsive shock and 5-HT autoreceptor activity in rat brain: an in vivo microdialysis study.
    Gur E; Lerer B; Newman ME
    J Neural Transm (Vienna); 1997; 104(8-9):795-804. PubMed ID: 9451712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological characterization of 8-OH-DPAT-induced inhibition of rat hippocampal 5-HT release in vivo as measured by microdialysis.
    Sharp T; Bramwell SR; Hjorth S; Grahame-Smith DG
    Br J Pharmacol; 1989 Nov; 98(3):989-97. PubMed ID: 2574066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-HT1A autoreceptor-mediated effects of the amperozide congeners, FG5865 and FG5893, on rat brain 5-hydroxytryptamine neurochemistry in vivo.
    Hjorth S; Pettersson G
    Eur J Pharmacol; 1993 Jul; 238(2-3):357-67. PubMed ID: 7691622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The novel 5-HT1A receptor antagonist, SDZ 216-525, decreases 5-HT release in rat hippocampus in vivo.
    Sharp T; McQuade R; Fozard JR; Hoyer D
    Br J Pharmacol; 1993 Jul; 109(3):699-702. PubMed ID: 8102935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular 5-hydroxytryptamine in median raphe nucleus of the conscious rat is decreased by nanomolar concentrations of 8-hydroxy-2-(di-n-propylamino) tetralin and is sensitive to tetrodotoxin.
    Bosker F; Klompmakers A; Westenberg H
    J Neurochem; 1994 Dec; 63(6):2165-71. PubMed ID: 7964736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the role of 5-HT1A autoreceptors and alpha 1-adrenoceptors in the inhibition of 5-HT release--I. BMY7378 and prazosin.
    Hjorth S; Bengtsson HJ; Milano S; Lundberg JF; Sharp T
    Neuropharmacology; 1995 Jun; 34(6):615-20. PubMed ID: 7566497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.